115 related articles for article (PubMed ID: 1541853)
21. The cytologic diagnosis of ovarian tumors by means of aspiration biopsy.
Angstrom T; Kjellgren O; Bergman F
Acta Cytol; 1972; 16(4):336-41. PubMed ID: 4504235
[No Abstract] [Full Text] [Related]
22. [Differential diagnosis of cystic ovarian tumors by determination of estradiol in cystic aspirate].
Ammann M; Hänggi W; Baumann U; Keller PJ
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):481-3. PubMed ID: 1889731
[TBL] [Abstract][Full Text] [Related]
23. [Peritoneal pseudomyxoma and mucinous ovarian cystadenocarcinoma. Apropos of 3 cases].
Cardin JL; Kerbrat P; Chevrant-Breton O; Bourdonnec P; Guerin D
Ann Chir; 1983 Jun; 37(5):369-73. PubMed ID: 6614803
[No Abstract] [Full Text] [Related]
24. [Markers of carcinoma of the ovary: serum cystine aminopeptidase and leucine aminopeptidase, reliable diagnostic parameters?].
Belgeri R; Monfrini O; Gilardi EM; Motta T; Frateschi M; Ferrario I
Ann Ostet Ginecol Med Perinat; 1984; 105(5):325-30. PubMed ID: 6534245
[No Abstract] [Full Text] [Related]
25. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
[TBL] [Abstract][Full Text] [Related]
26. Amylase in serous ovarian neoplasms.
Ramaswamy G; Jagadha V; Tchertkoff V
N Y State J Med; 1985 Mar; 85(3):113-5. PubMed ID: 2581198
[No Abstract] [Full Text] [Related]
27. [The prognosis of ovarian cancer depends on the CA125 value at the end of induction therapy].
Miwa K; Dozono H; Iemura K; Shinmura R; Nakamura Y; Matsumoto T; Ikeda S; Nagata Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):557-61. PubMed ID: 2056230
[TBL] [Abstract][Full Text] [Related]
28. [Histopathology of the ovarian tumors derived from the Müllerian (paramesonephric) epithelium and their differential diagnosis. I. Adenofibroma. Serous and mucinous cystadenomas and cystadenocarcinomas (author's transl)].
Jirásek JE
Cesk Gynekol; 1973 Nov; 38(9):705-8. PubMed ID: 4765179
[No Abstract] [Full Text] [Related]
29. [Neoplasm of the ovary as a cause of hyperamylasemia].
Pose Reino A; Suárez Dono J; Codesido Blanco T; Ferrón Vidán F; Lorenzo González A; Bugallo Paz L
An Med Interna; 1989 Apr; 6(4):207-8. PubMed ID: 2485076
[TBL] [Abstract][Full Text] [Related]
30. Ovarian giant cell tumor with cystadenocarcinoma.
Veliath AJ; Sankaran V; Aurora AL
Arch Pathol; 1975 Sep; 99(9):488-91. PubMed ID: 1164251
[TBL] [Abstract][Full Text] [Related]
31. [Morphological prognosis factors in ovarian carcinoma].
Stegner HE
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):425-30. PubMed ID: 2993093
[TBL] [Abstract][Full Text] [Related]
32. Tubulocystic ovarian clear cell carcinoma with abundant fibrous stroma: malignant clear cell adenofibroma.
Chan YJ; Ling F
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):87-91. PubMed ID: 10645058
[TBL] [Abstract][Full Text] [Related]
33. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma.
Roth LM; Langley FA; Fox H; Wheeler JE; Czernobilsky B
Cancer; 1984 Mar; 53(5):1156-63. PubMed ID: 6692303
[TBL] [Abstract][Full Text] [Related]
34. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
[TBL] [Abstract][Full Text] [Related]
35. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
Bidart JM; Bellet D
Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and therapy of malignant ovarian tumors at the 1st University Hospital for Women in Vienna between 1956 and 1964].
Kofler E; Siyawoschi D
Osterr Z Erforsch Bekampf Krebskr; 1972; 27(6):375-91. PubMed ID: 4678931
[No Abstract] [Full Text] [Related]
37. A case of double cancer (pancreatic and ovarian adenocarcinomas) diagnosed by exfoliative and fine needle aspiration cytology.
Niwa K; Yoshimi N; Sugie S; Sakamoto H; Tanaka T; Kato K; Kaneko H; Mori H
Jpn J Clin Oncol; 1988 Jun; 18(2):167-73. PubMed ID: 3379784
[TBL] [Abstract][Full Text] [Related]
38. Surface (germinal) epithelium and related ovarian neoplasms.
Blaustein A
Pathol Annu; 1981; 16 Pt 1():247-94. PubMed ID: 7329732
[No Abstract] [Full Text] [Related]
39. Characterization and survival of patients with serous cystadenocarcinoma of the ovaries.
Demopoulos RI; Bigelow B; Blaustein A; Chait J; Gutman E; Dubin N
Obstet Gynecol; 1984 Oct; 64(4):557-63. PubMed ID: 6483302
[TBL] [Abstract][Full Text] [Related]
40. [Outpatient care of patients with ovarian cancer after primary treatment and the prevention of recurrence].
Nechaeva ID; Vinokurov VL
Vopr Onkol; 1986; 32(4):39-43. PubMed ID: 3705526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
